Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LRRK2 mutations and Parkinson's disease in Sardinia--A Mediterranean genetic isolate.

Parkinsonism & related disorders - 1 Feb 2007

Cossu Giovanni, van Doeselaar Marina, Deriu Marcello, Melis Maurizio, Molari Andrea, Di Fonzo Alessio, Oostra Ben A, Bonifati Vincenzo

Abstract excerpt

The Leucine-Rich Repeat Kinase 2 (LRRK2) Gly2019Ser mutation is frequent among Parkinson's disease (PD) patients from the Arab, Jewish, and Iberian populations, while another mutation, Arg1441Gly, is common in the Basque population. We studied the prevalence of these mutations in Sardinia, a Medi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Italy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Mutation

Share to Parkinson Disease

Share to Penetrance

Share to Protein Serine-Threonine Kinases

Source

Identifiers

PMID: 17064949
DOI: 10.1016/j.parkreldis.2006.06.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17064949-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LRRK2 mutations and Parkinson's disease in Sardinia--A Mediterranean genetic isolate.PMID 17064949Read ↗

Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.Semantic proximity Read ↗

The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: clinical and demographic characteristics.Semantic proximity Read ↗

The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy.Semantic proximity Read ↗

Is the G2019S LRRK2 mutation common in all southern European populations?Semantic proximity Read ↗

LRRK2 mutations are a common cause of Parkinson's disease in Spain.Semantic proximity Read ↗

LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity.Semantic proximity Read ↗

Parkinson's disease associated with LRRK2-R1441C mutation: Characterization and comparison with other LRRK2 mutations.Semantic proximity Read ↗

Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.Semantic proximity Read ↗

An exome study of Parkinson's disease in Sardinia, a Mediterranean genetic isolate.Semantic proximity Read ↗

LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease.Semantic proximity Read ↗

High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.Semantic proximity Read ↗

The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.